Xenetic Biosciences, Inc. current report, 16 January 2014

Xenetic Biosciences, Inc. - Form 8-K Summary

Business Context and Reporting Period

This Current Report (Form 8-K) was filed on January 16, 2014, by Xenetic Biosciences, Inc., a Nevada corporation. The report discloses a material definitive agreement entered into by the company's wholly-owned subsidiary, General Aircraft, Inc.

Key Financial Metrics

The filing does not provide consolidated revenue, profit, cash flow, margin, debt, or liquidity metrics for the company. The only financial data disclosed relates to the specific terms of a new lease agreement:

  • Lease Rate: $200 per hour.
  • Minimum Usage: 40 hours per month (effective March 1, 2014).
  • Asset: R44 Raven II helicopter.

Material Changes

The primary material change is the execution of a Helicopter Lease Agreement with Coast Flight Academy, LLC. Under this agreement, the subsidiary leases an R44 Raven II helicopter. The lessee (Coast) assumes responsibility for hangar parking, insurance, fuel, operating oil, and regular maintenance and repairs. The agreement is set to terminate on December 31, 2015, or when the helicopter reaches 2,200 total hours, whichever occurs first.

Guidance, Outlook, and Risks

The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of general corporate risks. The agreement includes a termination clause allowing either party to end the contract with 120 days' written notice.

Key Facts for Investor Verification

  • Verify the operational status and valuation of the R44 Raven II helicopter being leased.
  • Confirm the financial impact of the subsidiary, General Aircraft, Inc., on the parent company's overall liquidity.
  • Monitor the lessee's (Coast Flight Academy, LLC) ability to meet the 40-hour monthly minimum requirement starting March 1, 2014.
  • Review the full text of the Helicopter Lease Agreement (Exhibit 10.1) for additional covenants not summarized in this report.